HRH Dr. Maha bint Mishari AlSaud

HRH Dr. Maha AlSaud is the Vice President of External Relations and Advancement at Alfaisal University (2014-present), a fully accredited NCAAA institute of higher education in the Kingdom of Saudi Arabia. HRH Dr. Maha spearheaded the enrolment of women in 2011 and serves as a member of the Board of Trustees, and Chairperson of the External Relations Advisory Board. HRH Dr. Maha is one of the founders and former Governor of American College of Physicians (ACP 2015 - 2019) – Saudi Arabia. She holds an MBBS degree from King Saud University (Riyadh, Kingdom of Saudi Arabia), College of Medicine (1986). She completed the Residency program at George Washington University Hospital for internal Medicine (1993). She acquired the American Board of Internal Medicine Certification (1994) and continues to hold it. She was also a Board Member at the Primary Vascular Research Institute.  She is also the President of George Washington University Medical Alumni, for Saudi Arabia and Gulf region and she is the Lead Co-Chair of the Taskforce #9 “Migration and Young Societies” at G20 Saudi Arabia 2020.

Ian Campbell

Ian Campbell is  VP of Innovation & Economic Development and Executive Director of Special Projects- Office of the President. He collaborates with the University researchers and leadership to help accelerate the digital economy in the Kingdom. He also supports the University’s forward vision to leverage KAUST science and innovation to make an impact beyond the walls of the campus itself, and to create collaborations and identify opportunities where KAUST can contribute. The aim of the Special Projects is to convene minds and resources together to work on impactful projects and to deliver solutions to benefit the wider Kingdom and beyond.

Career before joining KAUST: Executive Chair of Innovate UK, part of UK Research and Innovation, in 2020. He also directed Health and Life Sciences. Led the initiative to secure Covid-19 response package from the British government in 2020, to support thousands of UK businesses to survive and thrive through the pandemic.

Dr. Campbell has extensive entrepreneurial and business experience in the healthcare sector. Before Innovate UK, he was CEO of Arquer Diagnostics, which focuses on bladder and prostate cancer diagnosis. Before this, he spent 15 years in a variety of executive management roles within the health and life science sector.

He was recognized in Her Majesty Queen Elizabeth’s New Year Honors List and was appointed officer of the order of the British Empire (OBE) for services to innovation.

Nicholas Peppas

Nicholas Peppas works on a multidisciplinary approach of blending modern molecular and cellular biology with engineering principles to design the next-generation of medical systems and devices for patient treatment.  He is the Cockrell Family Regents Chair in the Departments of Biomedical Engineering, Chemical Engineering, and Pediatrics, at the University of Texas at Austin. His work focuses on nanomedicine, biomaterials, drug delivery, bionanotechnology and polymer physics. He has 1,600 publications with 128,000 citations and H=166. Peppas holds a Dipl. Eng. from the NTU of Athens (1971), an Sc.D. from MIT (1973), and honorary doctorates from the Universities of Ghent, Parma, Athens, Patras, Ljubljana, Thessaloniki, Santiago de Compostela, and the National Technical University of Athens. Also, he is an Honorary Professor at Sichuan University, Beihang University, PLA Hospital and Medical School, and Peking Medical Union College in China.